| Oct 1 |
MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
|
| Oct 1 |
Company News for Oct 1, 2024
|
| Oct 1 |
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
| Oct 1 |
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
|
| Oct 1 |
Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan
|
| Oct 1 |
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
|
| Sep 30 |
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
|
| Sep 29 |
Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed
|
| Sep 28 |
3 Surprisingly Underrated Stocks to Buy Right Now
|
| Sep 26 |
Moderna enters green after six straight sessions in red
|
